[1] Li TY, Yang Y, Zhou G, et al. Immune suppression in chronic hepatitis B infection associated liver disease: a review. World J Gastroenterol, 2019, 25(27):3527-3537. [2]Indolfi G, Easterbrook P, Dusheiko G, et al. Hepatitis B virus infection in children and adolescents. Lancet Gastroenterol Hepatol, 2019, 4(6):466-476. [3] Zhu J, Qi X, Yu H, et al. Acid suppression in patients treated with endoscopic therapy for the management of gastroesophageal varices: a systematic review and meta-analysis. Expert Rev Gastroenterol Hepatol, 2018, 12(6):617-624. [4] 丁荣蓉, 陆伟, 王雁冰, 等. 采用瞬时弹性成像技术和血清标志物预测丙氨酸转氨酶轻度升高的慢性乙型肝炎患者肝纤维化程度. 中华传染病杂志, 2019, 37(2):72-76. [5] Motosugi U, Roldán-Alzate A, Bannas P, et al. Four-dimensional flow MRI as a marker for risk stratification of gastroesophageal varices in patients with liver cirrhosis. Radiology, 2019, 290(1):101-107. [6] Enomoto H, Aizawa N, Ikeda N, et al. Association of the body mass index with the presence of gastroesophageal varices in compensated cirrhotic patients with hepatitis C viral infection. Ann Clin Lab Sci, 2018,48(6):801-804. [7] 中华医学会肝病学分会. 肝硬化腹水及相关并发症的诊疗指南. 实用肝脏病杂志, 2018, 21(1):21-31. [8] 中华医学会肝病学分会, 中华医学会消化病学分会, 中华医学会消化内镜学分会. 肝硬化门静脉高压食管胃静脉曲张出血的防治指南. 实用肝脏病杂志, 2016, 19(5):641-656. [9] Kim YJ, Raman SS, Yu NC, et al. Esophageal varices in cirrhotic patients: evaluation with liver CT. AJR, 2007,188(1):139-144. [10] Kanda T, Goto T, Hirotsu Y, et al. Molecular mechanisms driving progression of liver cirrhosis towards hepatocellular carcinoma in chronic hepatitis B and C infections: a review. Int J Mol Sci, 2019, 20(6):1358. [11] Hu Z, Zhang D, Swai J, et al. Risk of rebleeding from gastroesophageal varices after initial treatment with cyanoacrylate; a systematic review and pooled analysis. BMC Gastroenterol, 2020, 20(1):181. [12] Lee J, Sung PS, Eom KS, et al. Clinical characteristics of portal hypertension complicated by gastroesophageal varices in patients with myeloproliferative neoplasms. Clin Mol Hepatol, 2020, 26(1):78-82. [13] Tseng Y, Ma L, Luo T, et al. Patient response to endoscopic therapy for gastroesophageal varices based on endoscopic ultrasound findings. Gut Liver, 2018, 12(5):562-570. [14] 何志安, 余丽萍, 赖江琼, 等. RFI评估肝硬化并发食管胃底静脉曲张患者出血和门静脉血栓的价值分析. 实用肝脏病杂志, 2019, 22(6):888-891. [15] 许丹青, 杨晋辉. 肝硬化门静脉血栓形成的相关研究. 中华肝脏病杂志, 2020, 28(7):573-579. [16] Motosugi U, Roldán-Alzate A, Bannas P, et al. Four-dimensional flow MRI as a marker for risk stratification of gastroesophageal varices in patients with liver cirrhosis. Radiology, 2019, 290(1):101-107. [17] 沈萍, 马盛元, 许华宇, 等. MR弹性成像对慢性乙型肝炎肝纤维化的诊断价值. 中华放射学杂志, 2019, 53(8):710-714. [18] Tseng YJ, Zeng XQ, Chen J, et al. Computed tomography in evaluating gastroesophageal varices in patients with portal hypertension: a meta-analysis. Dig Liver Dis, 2016,48(7): 695-702. [19] 邢飞, 陆健, 张涛, 等. 肝硬化背景下MRI肝脏影像报告和数据系统LR-2、LR-3、LR-4类结节的变化与预后. 中华放射学杂志, 2018,52(4):272-276. [20] Morisaka H, Motosugi U, Ichikawa T, et al.MR-based measurements of portal vein flow and liver stiffness for predicting gastroesophageal varices. Magn Reson Med Sci, 2013,12(2):77-86. |